122 related articles for article (PubMed ID: 114190)
1. Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
Ikeda Y; Takano N; Matsushita H; Shiraki Y; Koide T; Nagashima R; Fujimura Y; Shindo M; Suzuki S; Iwasaki T
Arzneimittelforschung; 1979; 29(3):511-20. PubMed ID: 114190
[TBL] [Abstract][Full Text] [Related]
2. Central nervous actions and screening methods of antidepressants.
Ogura C; Kimishima K
Folia Psychiatr Neurol Jpn; 1972; 26(4):291-317. PubMed ID: 4144774
[No Abstract] [Full Text] [Related]
3. Pharmacological studies on 5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-5(H)-dibenz-(b,f)-azepine (carpipramine) dihydrochloride, a new psychotropic agent.
Nakanishi M; Tsumagari T; Okada T; Kasé Y
Arzneimittelforschung; 1968 Nov; 18(11):1435-41. PubMed ID: 5755909
[No Abstract] [Full Text] [Related]
4. [Pharmacological properties of MO-8282, a novel antidepressant].
Niho T; Ito C; Shibutani Y; Hashizume H; Yamaguchi K
Nihon Yakurigaku Zasshi; 1986 Oct; 88(4):309-20. PubMed ID: 3792961
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of 9-gamma-methylaminopropyl-9,10-dihydro-9,10-methanoanthracene-HCl (ID-9206-HCl), a new potent antidepressant.
Fukushima H; Nakamura M; Yamamoto H
Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):163-76. PubMed ID: 931463
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological properties of 6,6,9-trimethyl-9-azabicyclo (3,3,1)non-3 beta-yl-alpha, alpha-di(2-thienyl) glycolate hydrochloride monohydrate (PG-501), a new anti-parkinsonian agent].
Nose T; Kojima M; Ishida R; Shintomi K; Kowa Y
Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):387-405. PubMed ID: 5000167
[No Abstract] [Full Text] [Related]
9. [Pharmacological properties of new antidepressive agent azaphen].
Mashkovskiĭ MD; Polezhaeva AI
Farmakol Toksikol; 1969; 32(6):656-62. PubMed ID: 5381594
[No Abstract] [Full Text] [Related]
10. Pharmacology of new tropine ethers with central activity.
György L; Pfeifer AK; Dóda M; Galambos E; Molnár J; Kraiss G; Nádor K
Arzneimittelforschung; 1968 May; 18(5):517-24. PubMed ID: 4387833
[No Abstract] [Full Text] [Related]
11. Pharmacological studies of 5-methyl-8-ethyl-sulfonyl-10-(2-dimethylaminoethyl)-5H-dibenzo (B,E) (1,4) diazepine-11 (10)-one (SM-307), an antidepressive substance.
Nose T; Kowa Y
Jpn J Pharmacol; 1971 Feb; 21(1):47-55. PubMed ID: 5005073
[No Abstract] [Full Text] [Related]
12. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of the new antidepressant levoprotiline.
Noguchi S; Okada M; Inukai T
Arzneimittelforschung; 1992 Jun; 42(6):787-94. PubMed ID: 1418032
[TBL] [Abstract][Full Text] [Related]
14. Preferential inhibition of type B-MAO by new compounds, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1h-indazole(Fs32) and its N-desmethylated derivative (FS97).
Koide T; Uyemura K
Neuropharmacology; 1980 Sep; 19(9):871-5. PubMed ID: 7422097
[No Abstract] [Full Text] [Related]
15. Pharmacologic evaluation of aletamine (alpha-allylphenethylamine hydrochloride) as an antidepressant.
Hitchens JT; Orzechowski R; Goldstein S; Shemano I
Toxicol Appl Pharmacol; 1972 Mar; 21(3):302-14. PubMed ID: 5063697
[No Abstract] [Full Text] [Related]
16. The pharmacology of iprindole, a new antidepressant.
Gluckman MI; Baum T
Psychopharmacologia; 1969; 15(3):169-85. PubMed ID: 4390823
[No Abstract] [Full Text] [Related]
17. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
Boksay IJ; Popendiker K; Weber RO; Söder A
Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
[TBL] [Abstract][Full Text] [Related]
18. Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain.
Koide T; Matsushita H
Neuropharmacology; 1981 Mar; 20(3):285-92. PubMed ID: 7266786
[No Abstract] [Full Text] [Related]
19. Pharmacological studies with N-3,4,5-trimethoxybenzoyl-heptamethylene imine (N-1157), a new antidepressant agent.
Pálosi E; Mészáros C; Szporny L
Arzneimittelforschung; 1969 Nov; 19(11):1882-7. PubMed ID: 5395660
[No Abstract] [Full Text] [Related]
20. Pharmacological evaluation of 3-(N-3,3-diphenylpropyl-N-methyl)-aminopropan-1-ol-hydrochloride (PF-82), a new type of antidepressant drug.
Shimizu M; Hirooka T; Karasawa T; Masuda Y; Oka M
Arzneimittelforschung; 1974 Feb; 24(2):166-73. PubMed ID: 4207353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
